Seven new dihydro-β-agarofurans, celastrofurans A-G (1-7), along with two known secondary metabolites, 9β-benzoyloxy-1α-furoyloxydihydro-β-agarofuran (8) and (1R,2R,4R,5S,7R,9S,10R)-2-acetoxy-9-benzoyloxy-1-furoyloxydihydro-β-agarofuran (9) were obtained from the leaves of the Australian rainforest vine, Celastrus subspicata. The structures of the new compounds were determined by detailed spectroscopic (1D/2D NMR) and MS data analysis. The absolute configurations of compounds 1-4 were defined by ECD and single-crystal X-ray diffraction studies. All compounds were found to exhibit inhibitory activity on leucine transport in the human prostate cancer cell line LNCaP with IC50 values ranging from 7.0-98.9 μM. Dihydro-β-agarofurans 1-9 showed better potency than the Ltype amino acid transporter (LAT) family inhibitor, 2-aminobicyclo[2.2.1]-heptane-2carboxylic acid (BCH). L-type amino acid transporters (LATs) uptake neutral amino acids including leucine into cells. LATs are vital for protein synthesis as well as stimulating the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway. The mTORC1 pathway acts as a master regulator of cell growth, proliferation, and metabolism. 1 The LAT family is expressed in both normal and cancer cells, and the expression levels of LAT family members are upregulated in various human cancers, including prostate cancer. 2-5 Leucine plays an important role as a rate-limiting signaling molecule in the mTORC1 pathway; 6,7 therefore, targeting LATs by inhibiting leucine uptake affects cancer growth through the inhibition of mTORC1. 3
The relative configuration of 1 was determined based on the analysis of ROESY data ( Figure 2 ) and 1 H-1 H coupling constants. The β-orientation of H-1 was suggested by the large coupling constants between H-1 and H-2 (J1,2 = 12.0 Hz), while the ROESY correlations between H3-14 and H3-15 as well as between H-9 and H3-15 indicated that CH3-14, CH3-15 and H-9 were all α-oriented. The absolute configuration of 1 was resolved by the dibenzoate chirality method, 15, 16 which has been used routinely to determine the absolute configuration of dihydro-β-agarofurans bearing two benzoate chromophores. [17] [18] [19] The ECD spectrum of 1 ( Figure 4 ) exhibited a Davydov-type splitting with a positive first Cotton effect at 240 nm (Δε = +4.08) and a negative second Cotton effect at 223 nm (Δε = -2.67) due to the coupling of the two benzoates at C-1α and C-9β. Thus, the absolute configuration of 1 was assigned as (1S,4R,5S,7R,9S,10S)-1,9-dibenzoyloxydihydro-β-agarofuran.
Celastrofuran B (2) was purified as stable colorless crystals and was assigned the molecular formula C31H36O7 following analysis of the (+)-HRESIMS data. The 1 H and 13 C NMR spectra of 2 were similar with those of 1, except for the presence of an acetate group (δH 1.79 and δC 21.2, 170.9) and an additional oxygenated methine (δH 5.33 and δC 69.5) in 2. Detailed analysis of the HMBC spectrum revealed that the acetate group was located at C-2 in 2 since correlations from both H-2 (δH 5.33) and the methyl protons at δH 1.79 to an ester carbonyl carbon at δC 170.9 were observed. The relative configuration of 2 was assigned following analysis of 1 H-1 H coupling constants and the ROESY spectrum. A large coupling constant (J1,2 = 10.6 Hz) between H-1 and H-2 indicated the β-orientation of H-1 and the α-orientation of H-2. The ROESY correlations between H3-14 and H3-15; and between H-9 and H3-15 indicated that CH3-14, CH3-15 and H-9 were cofacial. The structure of 2 was confirmed by a single-crystal X-ray diffraction study (Figure 3 ), which also established its absolute configuration as (1R,2R,4R,5S,7R,9S,10R)-2-acetoxy-1,9-dibenzoyloxydihydro-β-agarofuran.
The molecular formula of compound 3 was determined as C31H36O8 based on the (+)-HRESIMS data. The 1 H and 13 C NMR spectra of 3 were very similar with those of 2.
Comparison of the NMR and MS data between 2 and 3 revealed that both compounds had the same ester substitution, but the MS data indicated that the latter natural product contained a -CHOH-moiety. The hydroxy group was positioned at C-8 based on the deshielded resonances of CH-8 (δH 4.12 and δC 72.8), and was further supported following detailed HMBC analysis (see Supporting Information). The α-orientation of OH-8 was assigned by the ROESY correlation between H-8 and H3-12. The ECD spectrum of 3 ( Figure 4 ) exhibited a positive Cotton effect at 241 nm (Δε = +10.58) and a negative Cotton effect at 221 nm (Δε = -4.37) due to the coupling of the two benzoate chromophores at C-1α and C-9β. Therefore, the structure of 3 (celastrofuran C) was assigned as (1R,2R,4R,5S,7S,8R,9R,10R)-2-acetoxy-1,9-dibenzoyloxy-8-hydroxydihydro-β-agarofuran.
Celastrofuran D (4), isolated as stable colorless crystals, was assigned the molecular formula, C29H32O9, following analysis of the (+)-HRESIMS and NMR data. The 1 H and 13 C NMR data of 4 were similar to those of compound 3, indicating that compound 4 was based on the same dihydro-β-agarofuran skeleton. Analysis of the NMR data of 4 and comparison with 3 revealed that the benzoate moiety at C-1 in 3 was replaced by a furoate group in 4.
This was established by HMBC correlations ( Figure 5 ) from H-1 (δH 5.86) to the carbonyl carbon of the furoate group at δC 161.3. In addition, the secondary hydroxy group in 3 was oxidized to a carbonyl (C-8) in 4. HMBC correlations from H-6, H-7, and H-9 to a carbonyl carbon at δC 205.6 further confirmed the presence of a ketone functionality at C-8 in 4. The relative configuration of 4 was ascertained to be the same as that of 3 following ROESY data ( Figure 5 ) analysis. The structure of celastrofuran D (4) was confirmed unequivocally by Xray crystallography studies (Figure 3 ), which also permitted the assignment of its absolute configuration. Accordingly, compound 4 was assigned as (1R,2R,4R,5S,7R,9R,10S)-2acetoxy-1,9-difuroyloxy-8-oxodihydro-β-agarofuran.
Celastrofuran E (5), a stable colorless gum, was found to possess a molecular formula of C29H34O9 following interpretation of its (+)-HRESIMS and NMR data. The 1 H and 13 The molecular formula of compound 6 was assigned as C27H32O10 by (+)-HRESIMS and 13 C NMR data analysis. The NMR spectra of 6 showed it to have similar features to those of 5, with the only difference being the replacement of the benzoate group at C-9 in 5 by a furoate group in 6. This was supported by HMBC correlations from H-1 (δH 5.56) and the protons of the furoate group (δH 6.39, 7.26) to the ester carbonyl carbon at δC 162.2. The relative configuration of 6 was deemed to be identical as 5 following ROESY data interpretation. Hence, the structure of 6 was established as 2β-acetoxy-1α,9α-difuroyloxy-8αhydroxydihydro-β-agarofuran and was assigned the trivial name celastrofuran F (6) .
Celastrofuran G (7) was obtained as a white amorphous powder. The (+)-HRESIMS data indicated that 7 had a molecular formula of C31H36O10. Analysis of the NMR spectra indicated that 7 was related structurally to 5, with the difference being the presence of an additional acetate group (δH 1.96 and δC 21.2, 169.7) in 7. HMBC correlations from H-8 (δH 5.64) and the acetate methyl (δH 1.96) to the ester carbonyl carbon at δC 169.7 positioned the acetate group at C-8. The same relative configuration previously determined for 5 was also assigned for 7 following analysis of 1 H-1 H coupling constants and the ROESY spectrum.
Therefore, the structure of compound 7 was elucidated as 2β,8α-diacetoxy-9α-benzoyloxy-1α-furoyloxy-dihydro-β-agarofuran.
The known compounds 9β-benzoyloxy-1α-furoyloxydihydro-β-agarofuran (8) and (1R,2R,4R,5S,7R,9S,10R)-2-acetoxy-9-benzoyloxy-1-furoyloxydihydro-β-agarofuran (9) were identified by comparison of their spectroscopic data with those reported in the literature. 20, 21 Compound 8 was previously isolated from the root bark of Osyris lanceolata (Santalaceae), while compound 9 was obtained originally from the fruits of Maytenus jelskii (Celastraceae). It is worth mentioning that compound 9 has been reported to block Pglycoprotein in human MDR1 cells. 21 Herein, the ECD data are included for the known compounds 8 and 9, which were not reported in the original papers. Comparison of ECD spectra ( Figure 4 ) and the specific rotations of compounds 1 and 8 showed that both compounds had identical absolute configurations. Thus, the structure and absolute configuration of compound 8 was defined as (1S,4R,5S,7R,9S,10S)-9-benzoyloxy-1furoyloxydihydro-β-agarofuran. Previous studies on the seeds of C. subspicata have led to the isolation of 10 and 11, 13 but neither of these compounds was identified during our studies on the leaves of this vine.
Due to our previous discovery of dihydro-β-agarofurans that inhibited leucine transport, 10, 11 compounds 1-9 were evaluated for their effects on leucine transport in the LNCaP human prostate cancer cell line. All compounds inhibited leucine uptake in LNCaP cells with IC50 values ranging from 7.0 to 98.9 µM (Table 3 and Figure 7) , which was lower than the currently utilized LAT family inhibitor BCH (IC50 = 4060 µM). 22 Comparison of the leucine uptake inhibition of compounds 1-3, 8, and 9 showed that compounds without a hydroxy moiety at C-8 (1, 2, 8, and 9) were more active than the natural product 3, which has C-8 hydroxylation. This indicated that the presence of OH-8
decreased the leucine uptake inhibition. Furthermore, substituting the C-8 methylene unit in 9
with a ketone functionality in 4 resulted in 2.6-fold decrease in the activity. Compounds 5-7
also exhibited leucine uptake inhibition with 7 being the most active in this series with an IC50 value of 15.2 µM. These data suggested that for this particular agarofuran series acetylation rather than hydroxylation at C-8 conferred better activity. For example, replacing the hydroxy group (OH-8) of 5 with an acetoxy group in 7 resulted in a 6.5-fold increase in leucine uptake activity. Moreover, the minimal difference between the activity of 5 and 6
indicated that the type of ester substitution for this series had no profound effect on bioactivity. In conclusion, these studies identified celastrofuran B (2) as the most active compound that inhibited leucine uptake with an IC50 value of 7.0 µM (Figure 7 ). This activity is comparable or better than the recently reported natural products from the plants Pittosporum venulosum, Maytenus bilocularis, and Denhamia pittosporoides. 10, 11, 22, 23 These findings warrant future investigation on how these compounds inhibit leucine uptake in cancer cells.
EXPERIMENTAL SECTION
General Experimental Procedures. Melting points were measured using a Cole-Parmer melting point apparatus and are uncorrected. Specific rotations were determined on a JASCO P-1020 polarimeter. UV spectra were recorded using a JASCO V-650 UV/vis spectrophotometer. ECD spectra were obtained on a JASCO J-715 spectropolarimeter and processed using the software SDAR. 24 Table 2 and δC 170. Table 2 and δC 170. . These data were used to generate the IC50 values in Table 3 . 
